{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:32:44Z","timestamp":1762029164118,"version":"build-2065373602"},"reference-count":43,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.5551\/jat.59873","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T22:08:48Z","timestamp":1607465328000},"page":"82-98","source":"Crossref","is-referenced-by-count":7,"title":["Activated Factor XI is Increased in Plasma in Response to Surgical Trauma but not to Recombinant Activated FVII-Induced Thrombin Formation"],"prefix":"10.5551","volume":"29","author":[{"given":"Heiko","family":"R\u00fchl","sequence":"first","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Friemann","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Reda","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska I.","family":"Winterhagen","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Berens","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"P\u00f6tzsch","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Seligsohn U: Factor XI in Haemostasis and Thrombosis: Past, Present and Future. Thromb Haemost, 2007; 98: 84-89","DOI":"10.1160\/TH07-04-0246"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Emsley J, McEwan PA and Gailani D: Structure and function of factor XI. Blood, 2010; 115: 2569-2577","DOI":"10.1182\/blood-2009-09-199182"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Mohammed BM, Matafonov A, Ivanov I, Sun MF, Cheng Q, Dickeson SK, Li C, Sun D, Verhamme IM, Emsley J and Gailani D: An update on factor XI structure and function. Thromb Res, 2018; 161: 94-105","DOI":"10.1016\/j.thromres.2017.10.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Macfarlane RG: An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature, 1964; 202: 498-499","DOI":"10.1038\/202498a0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Davie EW and Ratnoff OD: Waterfall sequence for intrinsic blood clotting. Science, 1964; 145: 1310-1312","DOI":"10.1126\/science.145.3638.1310"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Naudin C, Burillo E, Blankenberg S, Butler L and Renn\u00e9 T: Factor XII Contact Activation. Semin Thromb Hemost, 2017; 43: 814-826","DOI":"10.1055\/s-0036-1598003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Maas C and Renn\u00e9 T: Coagulation factor XII in thrombosis and inflammation. Blood, 2018; 131: 1903-1909","DOI":"10.1182\/blood-2017-04-569111"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun MF, White-Adams TC, Smith SA, Hanson SR, McCarty OJ, Renn\u00e9 T, Gruber A and Gailani D: A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood, 2010; 116: 1981-3989","DOI":"10.1182\/blood-2010-02-270918"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) M\u00fcller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH and Renn\u00e9 T: Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell, 2009; 139: 1143-1156","DOI":"10.1016\/j.cell.2009.11.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kleinschnitz C, Stoll G, Bendszus M, Schuh K, Pauer HU, Burfeind P, Renn\u00e9 C, Gailani D, Nieswandt B and Renn\u00e9 T: Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med, 2006; 203: 513-518","DOI":"10.1084\/jem.20052458"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Matafonov A, Leung PY, Gailani AE, Grach SL, Puy C, Cheng Q, Sun MF, McCarty OJ, Tucker EI, Kataoka H, Renn\u00e9 T, Morrissey JH, Gruber A and Gailani D: Factor XII inhibition reduces thrombus formation in a primate model. Blood, 2014; 123: 1739-1746","DOI":"10.1182\/blood-2013-04-499111"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) James P, Salomon O, Mikovic D and Peyvandi F: Rare bleeding disorders \u2013 bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency. Haemophilia, 2014; 20 Suppl 4: 71-75","DOI":"10.1111\/hae.12402"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Wheeler AP and Gailani D: Why factor XI deficiency is a clinical concern. Expert Rev Hematol, 2016; 9: 629-637","DOI":"10.1080\/17474086.2016.1191944"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Gailani D and Broze GJ Jr.: Factor XI activation in a revised model of blood coagulation. Science, 1991; 253: 909-912","DOI":"10.1126\/science.1652157"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Choi SH, Smith SA and Morrissey JH: Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood, 2011; 118: 6963-6970","DOI":"10.1182\/blood-2011-07-368811"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Geng Y, Verhamme IM, Smith SB, Sun MF, Matafonov A, Cheng Q, Smith SA, Morrissey JH and Gailani D: The dimeric structure of factor XI and zymogen activation. Blood, 2013; 121: 3962-3969","DOI":"10.1182\/blood-2012-12-473629"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Geng Y, Verhamme IM, Smith SA, Cheng Q, Sun M, Sheehan JP, Morrissey JH and Gailani D: Factor XI anion-binding sites are required for productive interactions with polyphosphate. J Thromb Haemost, 2013; 11: 2020-2028","DOI":"10.1111\/jth.12414"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) von dem Borne PA, Meijers JC and Bouma BN: Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood, 1995; 86: 3035-3042","DOI":"10.1182\/blood.V86.8.3035.bloodjournal8683035"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) von dem Borne PA, Cox LM and Bouma BN: Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. Blood Coagul Fibrinolysis, 2006; 17: 251-257","DOI":"10.1097\/01.mbc.0000224843.33216.5f"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sz\u00e9kely O, Borgi M and Lip GYH: Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation. Expert Opin Emerg Drugs, 2019; 24: 55-61","DOI":"10.1080\/14728214.2019.1591368"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Weitz JI and Fredenburgh JC: Factors XI and XII as Targets for New Anticoagulants. Front Med (Lausanne), 2017; 4: 19","DOI":"10.3389\/fmed.2017.00019"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) B\u00fcller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, Segers A, Verhamme P and Weitz JI; FXI-ASO TKA Investigators: Factor XI antisense oligonucleotide for prevention of venous thrombosis. N Engl J Med, 2015; 372: 232-240","DOI":"10.1056\/NEJMoa1405760"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bickmann JK, Baglin T, Meijers JCM and Renn\u00e9 T: Novel targets for anticoagulants lacking bleeding risk. Curr Opin Hematol, 2017; 24: 419-426","DOI":"10.1097\/MOH.0000000000000367"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) R\u00fchl H, Winterhagen FI, Berens C, M\u00fcller J, Oldenburg J and P\u00f6tzsch B: In vivo thrombin generation and subsequent APC formation are increased in factor V Leiden carriers. Blood, 2018; 131: 1489-1492","DOI":"10.1182\/blood-2017-12-823831"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) R\u00fchl H, Berens C, Winterhagen FI, Reda S, M\u00fcller J, Oldenburg J and P\u00f6tzsch B: Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin G20210G\uff1eA Carriers. Circ Res, 2019; 125: 523-534","DOI":"10.1161\/CIRCRESAHA.119.315037"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Friedrich MJ, Schmolders J, Rommelspacher Y, Strauss A, R\u00fchl H, Mayer G, Oldenburg J, Wirtz DC, M\u00fcller J and P\u00f6tzsch B: Activity Pattern Analysis Indicates Increased but Balanced Systemic Coagulation Activity in Response to Surgical Trauma. TH Open, 2018; 2: e350-e356","DOI":"10.1055\/s-0038-1673390"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hemker HC, Al Dieri R, De Smedt E and B\u00e9quin S: Thrombin generation, a function test ot the haemostatic-thrombotic system. Thromb Haemost, 2006; 96: 553-561","DOI":"10.1160\/TH06-07-0408"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Castoldi E and Rosing J: Thrombin generation tests. Thromb Res, 2011; 127 Suppl. 3: S21-S25","DOI":"10.1016\/S0049-3848(11)70007-X"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) M\u00fcller J, Becher T, Braunstein J, Berdel P, Gravius S, Rohrbach F, Oldenburg J, Mayer G and P\u00f6tzsch B: Profiling of active thrombin in human blood by supramolecular complexes. Angew Chem Int Ed Engl, 2011; 50: 6075-6078","DOI":"10.1002\/anie.201007032"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) R\u00fchl H, M\u00fcller J, Harbrecht U, Fimmers R, Oldenburg J, Mayer G and P\u00f6tzsch B: Thrombin inhibition profiles in healthy individuals and thrombophilic patients. Thromb Haemost, 2012; 107: 848-853","DOI":"10.1160\/TH11-10-0719"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) R\u00fchl H, Schr\u00f6der L, M\u00fcller J, Sukhitashvili S, Welz J, Kuhn WC, Oldenburg J, Rudlowski C and P\u00f6tzsch B: Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational study. PLoS One, 2014; 9: e105007","DOI":"10.1371\/journal.pone.0105007"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Becher T, M\u00fcller J, Akin I, Baumann S, Stach K, Borggrefe M, P\u00f6tzsch B and Lo\u00dfnitzer D: Characterization of circulating thrombin in patients with septic shock: a prospective observational study. J Thromb Thrombolysis, 2020; 50: 90-97","DOI":"10.1007\/s11239-019-01992-w"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Loeffen R, van Oerle R, de Groot PG, Waltenberger J, Crijns HJ, Spronk HM and ten Cate H: Increased factor XIa levels in patients with a first acute myocardial infarction: the introduction of a new thrombin generation based factor XIa assay. Thromb Res, 2014; 134: 1328-1334","DOI":"10.1016\/j.thromres.2014.09.015"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Loeffen R, van Oerle R, Leers MP, Kragten JA, Crijns H, Spronk HM and ten Cate H: Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events. PLoS One, 2016; 11: e0158355","DOI":"10.1371\/journal.pone.0158355"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) R\u00fchl H, Berens C, Winterhagen A, M\u00fcller J, Oldenburg J and P\u00f6tzsch B: Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion. PloS One, 2015; 10: e0145012","DOI":"10.1371\/journal.pone.0145012"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Prior SM, Cohen MJ, Conroy AS, Nelson MF, Kornblith LZ, Howard BM and Butenas S: Correlation between factor (F)XIa, FIXa and tissue factor and trauma severity. J Trauma Acute Care Surg, 2017; 82: 1073-1079","DOI":"10.1097\/TA.0000000000001449"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Prior SM, Park MS, Mann KG and Butenas S: Endogenous Procoagulant Activity in Trauma Patients and Its Relationship to Trauma Severity. TH Open, 2019; 3: e10-e19","DOI":"10.1055\/s-0038-1677030"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Matafonov A, Sarilla S, Sun MF, Sheehan JP, Serebrov V, Verhamme IM and Gailani D: Activation of factor XI by products of prothrombin activation. Blood, 2011; 118: 437-445","DOI":"10.1182\/blood-2010-10-312983"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Verhoef JJ, Barendrecht AD, Nickel KF, Dijkxhoorn K, Kenne E, Labberton L, McCarty OJ, Schiffelers R, Heijnen HF, Hendrickx AP, Schellekens H, Fens MH, de Maat S, Renn\u00e9 T and Maas C: Polyphosphate nanoparticles on the platelet surface trigger contact system activation. Blood, 2017; 129: 1707-1717","DOI":"10.1182\/blood-2016-08-734988"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Ivanov I, Shakhawat R, Sun MF, Dickeson SK, Puy C, McCarty OJ, Gruber A, Matafonov A and Gailani D: Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen. Thromb Haemost, 2017; 117:671-681","DOI":"10.1160\/TH16-09-0691"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Grover SP and Mackman N: Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis. Arterioscler Thromb Vasc Biol, 2018; 38: 709-725","DOI":"10.1161\/ATVBAHA.117.309846"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Lorentz CU, Verbout NG, Wallisch M, Hagen MW, Shatzel JJ, Olson SR, Puy C, Hinds MT, McCarty O, Gailani D, Gruber A and Tucker EI: Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial. Arterioscler Thromb Vasc Biol, 2019; 39: 799-809","DOI":"10.1161\/ATVBAHA.118.312328"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C and Raskob GE: Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA, 2020; 323: 130-139","DOI":"10.1001\/jama.2019.20687"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/1\/29_59873\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T04:08:15Z","timestamp":1641010095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/1\/29_59873\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.59873","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"type":"print","value":"1340-3478"},{"type":"electronic","value":"1880-3873"}],"subject":[],"published":{"date-parts":[[2022,1,1]]},"article-number":"59873"}}